3 ms·
What if to each publication of a non-null result, academics are given the opportunity to publish their nulls as well, if only as a appendix or better, a counter
by dleeftink 2y ago
What if to each publication of a non-null result, academics are given the opportunity to publish their nulls as well, if only as a appendix or better, a counterpublication to their main conclusions? I don't buy the argument that papers need be of max-n length, now that documents and journals can be easily stored and distributed.
I would love something like Living Papers [0][1] to take off, where the null an non-non results could be compared interactively on similar footing.
[0]: https://github.com/uwdata/living-papers https://github.com/uwdata/living-papers
[1]: https://idl.uw.edu/living-papers-template/ https://idl.uw.edu/living-papers-template/
- bluGill 2y agoA null result may be a dead end and so there is no related paper worth publishing it in. A null result should be published right away in a searchable place, but probably isn't worth a lot of effort in general. I tried X, it didn't work, here is the raw data.
- dleeftink 2y agoThat's my thought exactly--not a related paper but simply providing additional room for discussing the less shiny bits of the same experiment. Even if the whole thing is a null, the setup, instruments, dependencies and what methods worked/didn't work is worth describing by itself.
- acchow 2y agoAll of that - the setup, the instruments, dependencies, methods - should be pre-submitted to the journal before the experimental results arrive. The journal should be the one that uses the data from the experiment and runs your pre-submitted program over the data to produce a result. Papers need to be published backwards.
- bluGill 2y agoRight now you don't even know who will publish you paper until all that is done. Your experiment might be try some promising molecule/drug in a petri dish, and see what happens, if the results are amazing you will get in a different journal than if the results are something happens but the control molecule/drug is better.
- acchow 2y agoRight, I'm saying journals should be picking which to publish before the results arrive. They should even publish it before the results arrive. And then publish again after.
- bumby 2y agoI agree that in an idealized way, this would be much better. But what do you do about going through all this process and ending up with a bad reviewer?* In those cases, how would you handle re-submitting to a different journal without looking like you're creating those artifacts after-the-fact to suit your outcome? Would the pre-submittals need to be handled by some third party? * the current process still has a lot of luck in terms of getting assigned referees. Sometimes you just plain get a bad reviewer who just can't be bothered to read the submission carefully and is quick to reject it. I would hate to see a system that only allows for a single shot at publication
- naasking 2y agoThe review happens at the experimental design stage, not the publishing stage. Very little actual work has been done at that stage. After such a review, the journal agrees to publish your results regardless of outcome.